Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Keaney

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
The FEBS Journal|August 17, 2015
The dynamic blood-brain barrierJames Keaney, Matthew Campbell
Therapeutic Delivery|July 25, 2012
From RNA interference technology to effective therapy: how far have we come and how far to go?James Keaney, Matthew Campbell, Peter Humphries
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 14, 2019
Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's DiseaseJames Keaney, Julien Gasser, Gaëlle Gillet, et al.
Magnetic Resonance Imaging|January 21, 2019
Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRIDarragh E Crosbie, James Keaney, Lawrence C S Tam, et al.
Clinical Neuropathology|October 20, 2018
Neuropolypathology as a result of severe traumatic brain injury?Colin P Doherty, Eoin O'Keeffe, James Keaney, et al.
Frontiers in Molecular Neuroscience|July 7, 2023
Innate immune activation and aberrant function in the R6/2 mouse model and Huntington's disease iPSC-derived microgliaJulien Gasser, Gaelle Gillet, Jorge S Valadas, et al.
Frontiers in Immunology|August 14, 2023
Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALSMarie-Laure Clénet, James Keaney, Gaëlle Gillet, et al.
Human Molecular Genetics|September 7, 2010
Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)Lawrence C S Tam, Anna-Sophia Kiang, Matthew Campbell, et al.
Advances in Experimental Medicine and Biology|December 21, 2011
Protein misfolding and potential therapeutic treatments in inherited retinopathiesLawrence C S Tam, Anna-Sophia Kiang, Matthew Campbell, et al.
Journal of Neuropathology and Experimental Neurology|June 2, 2016
Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic EncephalopathyColin P Doherty, Eoin O'Keefe, Eugene Wallace, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
The FEBS Journal|August 17, 2015
The dynamic blood-brain barrierJames Keaney, Matthew Campbell
Therapeutic Delivery|July 25, 2012
From RNA interference technology to effective therapy: how far have we come and how far to go?James Keaney, Matthew Campbell, Peter Humphries
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 14, 2019
Inhibition of Bruton's Tyrosine Kinase Modulates Microglial Phagocytosis: Therapeutic Implications for Alzheimer's DiseaseJames Keaney, Julien Gasser, Gaëlle Gillet, et al.
Magnetic Resonance Imaging|January 21, 2019
Age-related changes in eye morphology and aqueous humor dynamics in DBA/2J mice using contrast-enhanced ocular MRIDarragh E Crosbie, James Keaney, Lawrence C S Tam, et al.
Clinical Neuropathology|October 20, 2018
Neuropolypathology as a result of severe traumatic brain injury?Colin P Doherty, Eoin O'Keeffe, James Keaney, et al.
Frontiers in Molecular Neuroscience|July 7, 2023
Innate immune activation and aberrant function in the R6/2 mouse model and Huntington's disease iPSC-derived microgliaJulien Gasser, Gaelle Gillet, Jorge S Valadas, et al.
Frontiers in Immunology|August 14, 2023
Divergent functional outcomes of NLRP3 blockade downstream of multi-inflammasome activation: therapeutic implications for ALSMarie-Laure Clénet, James Keaney, Gaëlle Gillet, et al.
Human Molecular Genetics|September 7, 2010
Prevention of autosomal dominant retinitis pigmentosa by systemic drug therapy targeting heat shock protein 90 (Hsp90)Lawrence C S Tam, Anna-Sophia Kiang, Matthew Campbell, et al.
Advances in Experimental Medicine and Biology|December 21, 2011
Protein misfolding and potential therapeutic treatments in inherited retinopathiesLawrence C S Tam, Anna-Sophia Kiang, Matthew Campbell, et al.
Journal of Neuropathology and Experimental Neurology|June 2, 2016
Blood-Brain Barrier Dysfunction as a Hallmark Pathology in Chronic Traumatic EncephalopathyColin P Doherty, Eoin O'Keefe, Eugene Wallace, et al.
Pageof 2